Circulating Baseline CXCR3+Th2 and Th17 Cell Proportions Correlate With Trabecular Bone Loss After 48 Weeks of Biological Treatment in Early Rheumatoid Arthritis

Scheffler, J. M., Drevinge, C., Lindholm, C., Gjertsson, I., Lend, K., Lund Hetland, M., Østergaard, M., Uhlig, T., Schrumpf Heiberg, M., Haavardsholm, E. A., Nurmohamed, M. T., Lampa, J., Sokka-Isler, T., Nordström, D., Hørslev-Petersen, K., Gudbjornsson, B., Gröndal, G., van Vollenhoven, R., Carlsten, H. & Lorentzon, M. & 3 others, Hultgård Ekwall, A.-K., Rudin, A. & Islander, U., Jan 2025, In: ACR open rheumatology. 7, 1, e11742.

Research output: Contribution to journal › Article › Academic › peer-review

Elevated neutrophil-to-lymphocyte and monocyte-to-lymphocyte ratios are associated with increased flares and elevated cardiovascular disease risk in gout

Stultz, R. D., Dai, L., van Geel, E., Gerritsen, M., Nurmohamed, M. T. & Lood, C., 2025, In: Scandinavian journal of rheumatology. 54, 2, p. 142-146 5 p.

Research output: Contribution to journal › Article › Academic › peer-review

Sex differences in patient-reported outcome measures and the association with clinical factors in axial spondyloarthritis patients treated with tumour necrosis factor inhibitors

Hellamand, P., van de Sande, M. G. H., Nurmohamed, M. T., van Vollenhoven, R. F., Hollick, R. J., Rotariu, O., Rotar, Z., Pirkmajer, K. P., Nordström, D., Hokkanen, A.-M., Michelsen, B., Kvien, T. K., Glintborg, B., Hetland, M. L., Østergaard, M., Loft, A. G., Pavelka, K., Zavada, J., Castrejon, I. & Otero-Varela, L. & 17 others, Gudbjornsson, B., Palsson, O., Olofsson, T., Wallman, J. K., Ciurea, A., Nissen, M. J., Yildirim, T. D., Onen, F., Codreanu, C., Mogosan, C., Santos, M. J., Vieira-Sousa, E., Iannone, F., Frediani, B., Ørnbjerg, L. M., Twisk, J. W. R. & van der Horst-Bruinsma, I. E., 1 Apr 2025, In: Nature Clinical Practice Rheumatology. 64, 4, p. 1853-1863 11 p.

Research output: Contribution to journal › Article › Academic › peer-review

Treatment with methotrexate plus oral prednisolone versus triple therapy (methotrexate/sulfasalazine/hydroxychloroquine) plus intra-articular glucocorticoids in early rheumatoid arthritis: a prespecified nonrandomised subgroup analysis of clinical and radiographic data at 48 weeks from the NORD-STAR trial's conventional treatment arm

Hetland, M. L., Heiberg, M. S., Sokka-Isler, T., Rudin, A., Østergaard, M., Haavardsholm, E., Rutanen, J., van Vollenhoven, R., Grondal, G., Ørnbjerg, L. M., Bøyesen, P., Lampa, J., Nurmohamed, M., Gudbjornsson, B., Uhlig, T., Kononoff, A., Lend, K., Krabbe, S., Olsen, I. C. & Sexton, J. & 1 others, Hørslev-Petersen, K., 2025, (E-pub ahead of print) In: Annals of the rheumatic diseases.

Research output: Contribution to journal › Article › Academic › peer-review

Changes in Tumor Necrosis Factor Inhibitor Drug Survival in Patients With Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis Over 15 Years

Visman, I. M., Atiqi, S., Boers, M., Twisk, J. W. R. & Nurmohamed, M. T., 2024, In: Journal of rheumatology. 51, 1, p. 84-87 4 p.

Research output: Contribution to journal › Article › Academic › peer-review